Susan Spitz

900 total citations
12 papers, 290 citations indexed

About

Susan Spitz is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Susan Spitz has authored 12 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Hematology. Recurrent topics in Susan Spitz's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Platelet Disorders and Treatments (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Susan Spitz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Platelet Disorders and Treatments (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Susan Spitz collaborates with scholars based in United States, Germany and Belgium. Susan Spitz's co-authors include Thomas M. Reilly, Hugh M. Davis, Charles Pendley, Bruce E. Miller, Manjula Reddy, Chia‐Lin J. Wang, Uma Prabhakar, Joseph J. Petraitis, Prabhakar K. Jadhav and Patricia Harlow and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Susan Spitz

12 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Spitz United States 7 119 75 58 51 49 12 290
Noriko Konishi Japan 12 56 0.5× 73 1.0× 25 0.4× 63 1.2× 33 0.7× 27 317
P. Hambleton Canada 6 185 1.6× 48 0.6× 52 0.9× 28 0.5× 8 0.2× 8 360
Go Urabe United States 14 355 3.0× 27 0.4× 49 0.8× 17 0.3× 7 0.1× 29 558
Sharon M. Jackson United Kingdom 5 125 1.1× 9 0.1× 11 0.2× 56 1.1× 33 0.7× 8 250
Lawrence W. Torley China 8 121 1.0× 42 0.6× 195 3.4× 27 0.5× 14 0.3× 13 366
Anja Schmid Switzerland 10 150 1.3× 59 0.8× 46 0.8× 7 0.1× 9 0.2× 15 318
M Kawakita Japan 10 175 1.5× 18 0.2× 83 1.4× 114 2.2× 7 0.1× 17 350
M. MIKI Japan 9 49 0.4× 48 0.6× 150 2.6× 5 0.1× 34 0.7× 9 355
Manni Luthra‐Guptasarma India 10 121 1.0× 7 0.1× 38 0.7× 46 0.9× 36 0.7× 37 297

Countries citing papers authored by Susan Spitz

Since Specialization
Citations

This map shows the geographic impact of Susan Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Spitz more than expected).

Fields of papers citing papers by Susan Spitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Spitz. The network helps show where Susan Spitz may publish in the future.

Co-authorship network of co-authors of Susan Spitz

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Spitz. A scholar is included among the top collaborators of Susan Spitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Spitz. Susan Spitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Piha‐Paul, Sarina A., Tara C. Mitchell, Solmaz Sahebjam, et al.. (2020). 419 Pharmacodynamic biomarkers demonstrate T-cell activation in patients treated with the oral PD-L1 inhibitor INCB086550 in a phase 1 clinical trial. Regular and Young Investigator Award Abstracts. A255–A255. 3 indexed citations
2.
Wu, Yuling, Hyun‐Jun Kim, Xu Liu, et al.. (2015). A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity. The AAPS Journal. 17(6). 1417–1426. 11 indexed citations
3.
Ahene, Ago, David W. Rusnak, Susan Spitz, et al.. (2012). Ligand Binding Assays in the 21st Century Laboratory: Automation. The AAPS Journal. 14(1). 142–153. 6 indexed citations
4.
Kubiak, Robert, Lanju Zhang, Jianchun Zhang, et al.. (2012). Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays. Journal of Pharmaceutical and Biomedical Analysis. 74. 235–245. 16 indexed citations
5.
6.
Billheimer, Jeffrey T., Ira B. Dicker, Richard Wynn, et al.. (2002). Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated. Blood. 99(10). 3540–3546. 47 indexed citations
7.
Billheimer, Jeffrey T., et al.. (2002). Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy. Thrombosis Research. 107(6). 303–317. 4 indexed citations
8.
Decicco, Carl P., David J. Nelson, Ying Luo, et al.. (2001). Glutamyl-γ-boronate Inhibitors of Bacterial Glu-tRNAGln Amidotransferase. Bioorganic & Medicinal Chemistry Letters. 11(18). 2561–2564. 19 indexed citations
9.
Batt, Douglas G., Joseph J. Petraitis, Gary A. Cain, et al.. (1999). Disubstituted Indazoles as Potent Antagonists of the Integrin αvβ3. Journal of Medicinal Chemistry. 43(1). 41–58. 63 indexed citations
10.
Reilly, Thomas M., et al.. (1993). Recombinant plasminogen activator inhibitor-1 protects platelets against the inhibitory effects of plasmin. Thrombosis Research. 71(1). 61–68. 4 indexed citations
11.
12.
Wang, Chia‐Lin J., et al.. (1992). Synthesis of phosphonopeptides as thrombin inhibitors. Tetrahedron Letters. 33(50). 7667–7670. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriko Konishi Breakdown of academic impact, for papers by P. Hambleton Breakdown of academic impact, for papers by Go Urabe Breakdown of academic impact, for papers by Sharon M. Jackson Breakdown of academic impact, for papers by Lawrence W. Torley Breakdown of academic impact, for papers by Anja Schmid Breakdown of academic impact, for papers by M Kawakita Breakdown of academic impact, for papers by M. MIKI Breakdown of academic impact, for papers by Manni Luthra‐Guptasarma
Rankless by CCL
2026